Therefore, an alteration known to cause an increased probability of mouse HCC tumorigenesis (MET overexpression) altered genes that were enriched in genes that participate in the network rearrangements characteristic of human HCC tumorigenesis, enriched for genes associated with sCNV in the tumors and for genes predictive of survival in AN. Here, MET is linked to hepatocellular carcinoma.